rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2011-3-18
|
pubmed:abstractText |
To prospectively assess the intestinal symptoms and fecal continence in patients who had undergone conformal radiotherapy (CRT) for prostate cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1879-355X
|
pubmed:author |
pubmed-author:AstnerSabrina TST,
pubmed-author:BuschRaymondeR,
pubmed-author:GeinitzHansH,
pubmed-author:HeinrichChristineC,
pubmed-author:KellerMonikaM,
pubmed-author:KerndlSimoneS,
pubmed-author:MollsMichaelM,
pubmed-author:PehlChristianC,
pubmed-author:PrauseNinaN,
pubmed-author:ScholzChristianC,
pubmed-author:ThammReinhardR,
pubmed-author:ZimmermannFrank BFB
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1373-80
|
pubmed:meshHeading |
pubmed-meshheading:21030158-Aged,
pubmed-meshheading:21030158-Aged, 80 and over,
pubmed-meshheading:21030158-Defecation,
pubmed-meshheading:21030158-Fecal Incontinence,
pubmed-meshheading:21030158-Gastrointestinal Hemorrhage,
pubmed-meshheading:21030158-Humans,
pubmed-meshheading:21030158-Male,
pubmed-meshheading:21030158-Middle Aged,
pubmed-meshheading:21030158-Mucus,
pubmed-meshheading:21030158-Prevalence,
pubmed-meshheading:21030158-Prospective Studies,
pubmed-meshheading:21030158-Prostate-Specific Antigen,
pubmed-meshheading:21030158-Prostatic Neoplasms,
pubmed-meshheading:21030158-Questionnaires,
pubmed-meshheading:21030158-Radiotherapy, Conformal,
pubmed-meshheading:21030158-Rectum,
pubmed-meshheading:21030158-Regression Analysis
|
pubmed:year |
2011
|
pubmed:articleTitle |
Longitudinal study of intestinal symptoms and fecal continence in patients with conformal radiotherapy for prostate cancer.
|
pubmed:affiliation |
Klinik und Poliklinik für Strahlentherapie und Radiologische Onkologie, Technische Universität München, München, Germany. hans.geinitz@lrz.tu-muenchen.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|